RxDataLab

RxDataLab provides scientific and technical due diligence on biotechnology companies. We use open-source intelligence (OSINT) to identify signals in public data that often go unnoticed. This includes regulatory filings, clinical trial registries, hiring trends, patent records, scientific publications, and other technical disclosures.

Most biotech research focuses on what companies say. We focus on what they do.

Our work is grounded in neuroscience, statistics, and custom, curated data sets. That foundation allows us to evaluate the actual technical progress behind drug programs and discovery platforms. We focus on companies and technologies where deep domain knowledge is essential, particularly in neuroscience, AI-enabled discovery, and scientifically complex medical devices.

We Cut Through the Hype

Investor research often depends on company presentations, analyst reports, and media coverage. While these can be useful they are highly curated. We look at operational activity and technical evidence that companies share through public sources, especially those released without fanfare.

We analyze:

• Clinical trial design, endpoints, and enrollment patterns
• Patent filings, ownership, and expiration strategies
• Technical hiring across R&D, clinical, and regulatory teams
• Scientific publications and consistency with public claims
• Regulatory activity, supply chain signals, and manufacturing moves

See our Education and Guides for more information on how we produce our original research.

Where We Excel

RxDataLab is a small, specialized firm. We work in areas where our background gives us a real advantage.

• Neuroscience Therapeutics & Devices We have hands-on experience in neuroscience and neurotechnology. Our work includes invasive devices, noninvasive monitoring tools, and translational approaches to psychiatric and neurological disorders.

• AI/ML Drug Discovery Platforms Many companies in this space lean heavily on buzzwords. We assess their models, pipelines, data strategies, and scientific output to understand what is real and what is marketing.

We offer custom research, targeted reports, and collaboration for investment teams, strategy groups, and corporate development professionals. If you need an independent technical review or a deeper look into a company’s science and operations, we are available.

Interested in learning more? Sign up for our newsletter, read our custom biotech industry research, and see our Education and Guides on how we create our unique data sets.